Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
11/10/1994 | CA2161681A1 Water soluble derivatives of camptothecin and their use as antitumor agents |
11/10/1994 | CA2161671A1 Methods of treating and detecting cancer using viruses |
11/10/1994 | CA2161656A1 Combined treatment of iron depletion and igg antibody |
11/10/1994 | CA2161548A1 Phosphoramidates useful as antitumor agents |
11/10/1994 | CA2161531A1 Dna profiles as an indicator of cellular redox potential and cancer risk |
11/10/1994 | CA2161230A1 Novel peptide nucleic acids |
11/10/1994 | CA2160909A1 Cell-targeted lytic pore-forming agents |
11/10/1994 | CA2139129A1 Peptidyl derivatives and their use as metalloproteinase inhibitors |
11/10/1994 | CA2139128A1 Peptidyl derivatives as metalloproteinase inhibitors |
11/09/1994 | EP0623676A1 Metalloproteinase inhibitor |
11/09/1994 | EP0623675A1 Altered affinity polypeptides of metal chelate binding antibodies |
11/09/1994 | EP0623615A1 Adhesion-receptor antagonists |
11/09/1994 | EP0623612A1 Terazosin polymorph and pharmaceutical composition |
11/09/1994 | EP0623606A2 Peptidic ketones as interleukin-1beta-converting enzyme inhibitors |
11/09/1994 | EP0623592A1 Peptide analogs as irreversible interleukin-1beta protease inhibitors |
11/09/1994 | EP0623346A1 Inhibitor for metastasis of malignant tumor |
11/09/1994 | EP0623215A1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
11/09/1994 | EP0623143A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
11/09/1994 | EP0623140A1 Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids |
11/09/1994 | EP0623134A1 Metal complexes of water soluble texaphyrins |
11/09/1994 | EP0623120A1 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
11/09/1994 | EP0623020A1 Pyropheophorbides and their use in photodynamic therapy |
11/09/1994 | EP0616493A4 Methods and compositions for reducing multi-drug resistance. |
11/09/1994 | EP0152477B1 Polypeptide-induced monoclonal antibodies to oncoproteins |
11/09/1994 | CN1094725A Methods for the preparation of novel sidechain-bearing taxanes and intermediates thereof |
11/09/1994 | CN1094720A New taxoids, their preparation and pharmaceutical compositions containing them |
11/08/1994 | US5362831 Polymer-bound paclitaxel derivatives |
11/08/1994 | US5362733 Lipid peroxidation prevention |
11/08/1994 | US5362732 Boronated compounds |
11/08/1994 | US5362730 Solvent extraction for compounds for treatment of hypertension |
11/08/1994 | US5362729 Dihydropyridine derivatives useful in antitumor therapy |
11/08/1994 | US5362718 Antibody inhibitors, antiinflammatory agents, fungicides, antitumor agents |
11/08/1994 | US5362716 Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines |
11/08/1994 | CA2123055A1 Peptidic ketones as interleukin-1 beta-converting enzyme inhibitors |
11/08/1994 | CA2122960A1 Polycyclic compounds and processes for the preparation thereof |
11/08/1994 | CA1332941C N-alkylated quaternary nitrogen containing heterocycles |
11/08/1994 | CA1332940C N-alkylated quaternary nitrogen-containing heterocycles |
11/08/1994 | CA1332939C 2,5,6-substituted-n -alkylpyrimidines |
11/08/1994 | CA1332938C N-alkylated quaternary nitrogen-containing heterocycles |
11/02/1994 | EP0622375A1 Chrysospermines, peptide drugs from Apiocrea chrysosperma having pharmacological activity, process for their production, and their use |
11/02/1994 | EP0622361A1 Heterocyclic compounds as bradykinin antagonists |
11/02/1994 | EP0622080A2 Gelatinase A inhibitor |
11/02/1994 | EP0621865A1 Rapamycin derivative and its medicinal use |
11/02/1994 | EP0621787A1 Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed |
11/02/1994 | EP0621785A1 Use of aqueous solutions containing peroxobisulphate ions for the treatment of malignant cells. |
11/02/1994 | EP0621773A1 Formulation and use of carotenoids in treatment of cancer |
11/02/1994 | EP0426667B1 Composition for macrophage activation |
11/02/1994 | EP0394265B1 Method for size separation of particles |
11/02/1994 | CN1094446A ECK receptor ligands |
11/02/1994 | CN1094445A Fik-1 as receiptor of growth factor of blood vessel inner-skin |
11/02/1994 | CN1094401A Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
11/01/1994 | US5360803 Composition and method for treating cancer |
11/01/1994 | US5360117 Process for the extraction of peat and apparatus for carrying out the process |
11/01/1994 | CA1332808C Polyester-based composition for the controlled release of medicinal substances |
10/30/1994 | CA2122227A1 Peptide analogs as irreversible interleukin-1.beta. protease inhibitors |
10/27/1994 | WO1994024297A1 Defective recombinant adenoviruses for gene therapy of tumours |
10/27/1994 | WO1994024285A1 Macrophage inflammatory protein variants |
10/27/1994 | WO1994024167A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
10/27/1994 | WO1994024163A2 Bispecific antigen-binding molecules |
10/27/1994 | WO1994024152A1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same |
10/27/1994 | WO1994024151A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
10/27/1994 | WO1994024146A1 Novel androgens and anabolic agents |
10/27/1994 | WO1994024145A1 Derivatives of triterpenoid acids and uses thereof |
10/27/1994 | WO1994024143A1 Method of forming oligonucleotides |
10/27/1994 | WO1994024107A1 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents |
10/27/1994 | WO1994024094A1 Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
10/27/1994 | WO1994024093A1 Ornithine decarboxylase inhibiting cyclic aminooxy compounds |
10/27/1994 | WO1994023731A1 An extract of freshwater mussel, methods of the extraction and uses thereof |
10/27/1994 | WO1994023725A1 Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid |
10/27/1994 | CA2160370A1 Derivatives of triterpenoid acids and uses thereof |
10/27/1994 | CA2160224A1 Bispecific antigen-binding molecules |
10/27/1994 | CA2160144A1 Clam extract, the method of preparation and use thereof |
10/27/1994 | CA2158972A1 1,5-benzodiazepine derivatives having cck and/or gastrin antogonistic activity |
10/27/1994 | CA2137833A1 Amino-sugars and glycoproteins, and methods for their preparation; pharmaceutical preparations containing these amino-sugars or glycoproteins, and the uses of these pharmaceuticalpreparations |
10/27/1994 | CA2135782A1 Ornithine decarboxylase inhibiting cyclic aminooxy compounds |
10/27/1994 | CA2135781A1 Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
10/26/1994 | EP0621270A1 Collagenase inhibitor |
10/26/1994 | EP0621039A1 Keyhole limpet hemocyanin composition with enhanced anti-tumor activity against bladder cancer |
10/26/1994 | EP0620826A1 Tie, a novel endothelial cell receptor tyrosine kinase |
10/26/1994 | EP0620742A1 Inactivation of cytotoxic drugs |
10/26/1994 | EP0620741A1 Cytotoxic drug therapy |
10/26/1994 | EP0620736A1 A method for the treatment of tumours and sarcomas |
10/26/1994 | EP0427747B1 Substituted phenylacetonitriles used to overcome resistance to drugs in anti-malarial therapy |
10/26/1994 | CN1094056A N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines |
10/26/1994 | CN1094052A Heterocycle-containing carbonic acid derivatives |
10/26/1994 | CN1094043A 喹唑啉衍生物 Quinazoline derivatives |
10/26/1994 | CN1094041A 6,7-modified paclitaxels |
10/26/1994 | CN1094036A Novel asymmetrically substituted bisnaphthalimides |
10/26/1994 | CN1094035A Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
10/26/1994 | CN1094034A 25Carboxylic derivative of vitamin D series, middle products in production of same and pharmaceutical containing same and use of same in treatment |
10/26/1994 | CN1093904A Compositions for the regulation of cytokine activity |
10/25/1994 | US5359124 Reacting benzylamine with cis-beta-phenylglycidic acid yields intermediate for anticarcinogenic taxol derivatives |
10/25/1994 | US5359120 Improvements relating to the production of prodrugs |
10/25/1994 | US5359078 Signal transduction inhibitor compounds |
10/25/1994 | US5359070 Antitumor agents |
10/25/1994 | US5359033 Cleaved dimers of mullerian inhibiting substance-like polypeptides |
10/25/1994 | US5358940 Chelate complexes and processes for their preparation |
10/25/1994 | US5358866 Using cytosine deaminase as marker |
10/25/1994 | US5358709 Antitumoral composition based on polypeptides having human interleukin 2 activity |
10/25/1994 | CA1332742C Cell growth inhibitors and methods of treating cancer and cell proliferative diseases |